Product Description
Overall, the global carotid shunt market was valued at nearly $125 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.7% to reach over $172 million.
The full report suite on the global market for carotid shunts includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2032, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Carotid Shunt Market Trends
A growing trend in the carotid shunt market is the increasing adoption of minimally invasive procedures supported by ongoing technological advancements. Both physicians and patients are showing a stronger preference for less invasive treatment options, such as carotid artery stenting (CAS), which involves placing a stent to expand the narrowed carotid artery and restore blood flow to the brain. This shift is largely driven by the perceived advantages of minimally invasive approaches, including shorter hospital stays, faster recovery times, and lower complication risks compared to traditional surgical methods like carotid endarterectomy (CAE).
Global Carotid Shunt Market Share Insights
- LeMaitre Vascular held the leading position in the global carotid shunt market in 2025. The company’s product portfolio includes the Pruitt F3® and Flexcel® carotid shunt lines, with the Pruitt® series historically serving as its most successful offering in this segment. LeMaitre Vascular markets its shunt products worldwide through direct sales operations in the United States, Canada, Europe, New Zealand, Australia, Japan and China. In addition, the company maintains an extensive network of distribution partners across regions including Brazil, South Africa, Turkey, Saudi Arabia, Russia, Thailand, Vietnam, Korea and Taiwan.
- Integra LifeSciences ranked as the second-leading competitor in the global carotid shunt market in 2025, supported by its Integra® Sundt Carotid Endarterectomy Shunt portfolio. The product line includes multiple configurations designed to meet varying surgical preferences, such as non-reinforced internal straight, reinforced internal straight, reinforced external loop and non-reinforced external loop shunts.
- Becton Dickinson held a modest share of the global carotid shunt market in 2025. The company’s product portfolio includes several carotid shunt models, such as the Bard® Carotid Bypass Shunt (Straight) available in multiple hole configurations, the Bard® Javid™ Carotid Bypass Shunt, the Bard® Brener™ Carotid Bypass Shunt, and the Bard® Burbank™ Carotid Bypass Shunt.
Global Carotid Shunt Market Segmentation Summary
- Carotid Shunt Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
